Rishi Dhawan, Neelabh Nayan, Jasmita Dass, Ganesh Kumar Viswanathan, Mukul Aggarwal, Pradeep Kumar, Manoranjan Mahapatra. "An open label randomized Study of low dose dasatinib (50 mg OD) vs standard dose dasatinib (100 mg OD) vs standard dose imatinib (400 mg OD) as upfront therapy in patients with newly diagnosed chronic myeloid leukemia (CML) - chronic Phase (CP)." Blood, 2025. doi:10.1182/blood-2025-5560